Hughes-Wilson Alexandra — SEC Form 4 filings
SEC reporting owner CIK 2005875. 9 Form 4 filings on record with FilingPulse; latest filed 2026-02-02.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-26 to 2026-02-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 3 filings — 281,644 shares, $1,050,360 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 84,008 shares @ $4.22 ($354,598) in Mereo BioPharma Group plc, filed 2024-09-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | See Remarks | 9 | — | 8 legs · 281,644 sh · $1,050,360 | 19 |
Form 4 filings — Hughes-Wilson Alexandra
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-02 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 183,750 (derivative) @ $0 · Grant/award (A): 61,250 (derivative) @ $0 · Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 154,000 (derivative) @ $0 | EDGAR |
| 2024-09-16 | 4 | Mereo BioPharma Group plc (MREO) | Sale (S): 7,769 @ $4.47 · Sale (S): 40,029 @ $4.47 · Sale (S): 16,304 @ $4.22 · Sale (S): 84,008 @ $4.22 | EDGAR |
| 2024-09-13 | 4 | Mereo BioPharma Group plc (MREO) | Option exercise (M): 40,000 @ $0 · Option exercise (M): 93,333 @ $1.40 · Option exercise (M): 75,000 @ $1.01 · Option exercise (M): 40,000 (derivative) @ $0 · Option exercise (M): 93,333 (derivative) @ $1.40 · Option exercise (M): 75,000 (derivative) @ $1.01 | EDGAR |
| 2024-06-27 | 4 | Mereo BioPharma Group plc (MREO) | Sale (S): 10,134 @ $3.69 · Sale (S): 22,968 @ $3.39 | EDGAR |
| 2024-06-25 | 4 | Mereo BioPharma Group plc (MREO) | Option exercise (M): 60,000 @ $0 · Option exercise (M): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4/A | Mereo BioPharma Group plc (MREO) | Holdings only — no transactions reported | EDGAR |
| 2024-05-23 | 4 | Mereo BioPharma Group plc (MREO) | Option exercise (M): 93,333 @ $1.40 · Sale (S): 50,350 @ $2.99 · Tax withholding (F): 42,983 @ $1.40 · Option exercise (M): 75,000 @ $1.01 · Sale (S): 50,082 @ $2.94 · Tax withholding (F): 24,918 @ $1.01 · +2 more | EDGAR |
| 2024-01-26 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 196,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2005875 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →